An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged in the city of Wuhan, Hubei Province, China, in late 2019. Since then, the virus has spread globally and caused a pandemic. Assays that can measure the antiviral activity of antibodies or antiviral compounds are needed for SARS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Protoc Microbiol
Main Authors: Amanat, Fatima, White, Kris M., Miorin, Lisa, Strohmeier, Shirin, McMahon, Meagan, Meade, Philip, Liu, Wen‐Chun, Albrecht, Randy A., Simon, Viviana, Martinez‐Sobrido, Luis, Moran, Thomas, García‐Sastre, Adolfo, Krammer, Florian
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361222/
https://ncbi.nlm.nih.gov/pubmed/32585083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpmc.108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados